Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORIENTAL AROMATICS vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORIENTAL AROMATICS TATVA CHINTAN PHARMA ORIENTAL AROMATICS/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 7,119.2 77.0 9,249.6% View Chart
P/BV x 2.0 5.6 35.4% View Chart
Dividend Yield % 0.1 0.2 83.8%  

Financials

 ORIENTAL AROMATICS   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    ORIENTAL AROMATICS
Mar-23
TATVA CHINTAN PHARMA
Mar-23
ORIENTAL AROMATICS/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs7502,649 28.3%   
Low Rs2951,606 18.4%   
Sales per share (Unadj.) Rs252.3191.1 132.1%  
Earnings per share (Unadj.) Rs5.920.5 28.6%  
Cash flow per share (Unadj.) Rs11.624.8 46.9%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Avg Dividend yield %0.10.1 101.8%  
Book value per share (Unadj.) Rs185.7232.2 80.0%  
Shares outstanding (eoy) m33.6522.17 151.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.111.1 18.6%   
Avg P/E ratio x89.1103.7 85.9%  
P/CF ratio (eoy) x44.985.7 52.4%  
Price / Book Value ratio x2.89.2 30.7%  
Dividend payout %8.59.7 87.5%   
Avg Mkt Cap Rs m17,58247,157 37.3%   
No. of employees `000NANA-   
Total wages/salary Rs m528386 136.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,4914,236 200.4%  
Other income Rs m5857 101.2%   
Total revenues Rs m8,5494,294 199.1%   
Gross profit Rs m541572 94.6%  
Depreciation Rs m19496 203.3%   
Interest Rs m13086 151.5%   
Profit before tax Rs m275448 61.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-7 -1,093.2%   
Profit after tax Rs m197455 43.4%  
Gross profit margin %6.413.5 47.2%  
Effective tax rate %28.2-1.6 -1,781.1%   
Net profit margin %2.310.7 21.7%  
BALANCE SHEET DATA
Current assets Rs m6,3963,136 204.0%   
Current liabilities Rs m2,9812,361 126.3%   
Net working cap to sales %40.218.3 220.1%  
Current ratio x2.11.3 161.6%  
Inventory Days Days93 315.3%  
Debtors Days Days81773 1,123.3%  
Net fixed assets Rs m3,4684,304 80.6%   
Share capital Rs m168222 75.9%   
"Free" reserves Rs m6,0814,926 123.4%   
Net worth Rs m6,2495,148 121.4%   
Long term debt Rs m31642 748.0%   
Total assets Rs m9,8657,439 132.6%  
Interest coverage x3.16.2 50.1%   
Debt to equity ratio x0.10 616.2%  
Sales to assets ratio x0.90.6 151.2%   
Return on assets %3.37.3 45.7%  
Return on equity %3.28.8 35.8%  
Return on capital %6.210.3 60.0%  
Exports to sales %36.876.2 48.3%   
Imports to sales %35.456.9 62.3%   
Exports (fob) Rs m3,1273,229 96.8%   
Imports (cif) Rs m3,0082,409 124.9%   
Fx inflow Rs m3,1273,229 96.8%   
Fx outflow Rs m3,0082,409 124.9%   
Net fx Rs m119820 14.5%   
CASH FLOW
From Operations Rs m-223278 -80.3%  
From Investments Rs m-465-1,011 45.9%  
From Financial Activity Rs m781378 206.8%  
Net Cashflow Rs m94-357 -26.3%  

Share Holding

Indian Promoters % 74.2 72.0 103.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 16.5 3.0%  
FIIs % 0.1 3.7 2.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 28.0 92.3%  
Shareholders   25,875 73,730 35.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORIENTAL AROMATICS With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on CAMPH.& ALL vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CAMPH.& ALL vs TATVA CHINTAN PHARMA Share Price Performance

Period CAMPH.& ALL TATVA CHINTAN PHARMA
1-Day -2.87% 0.02%
1-Month 17.34% 9.97%
1-Year -10.12% -23.68%
3-Year CAGR -20.00% -18.73%
5-Year CAGR 9.99% -11.70%

* Compound Annual Growth Rate

Here are more details on the CAMPH.& ALL share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of CAMPH.& ALL hold a 74.2% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CAMPH.& ALL and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, CAMPH.& ALL paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of CAMPH.& ALL, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.